Autolus Therapeutics plc (6A3A) — Financial Flexibility Index
Autolus Therapeutics plc (6A3A) has a Financial Flexibility Index of -0.16x as of December 2025. Free cash flow of €-67.32 Million (operating CF €-67.32 Million minus capex €0.00) represents 0% of total liabilities (€410.94 Million). Check 6A3A strategic asset allocation to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Autolus Therapeutics plc Financial Flexibility Index (2017–2025)
Historical Financial Flexibility Index trend for Autolus Therapeutics plc across 9 annual periods. See Autolus Therapeutics plc current assets vs equity to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Autolus Therapeutics plc (2017–2025)
Year-by-year free cash flow to debt coverage for Autolus Therapeutics plc. For the full company profile including market capitalisation, see market cap of Autolus Therapeutics plc.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.62x | €-256.44 Million | €-283.57 Million | €410.94 Million | ▼ -29.4% |
| 2024 | -0.48x | €-171.45 Million | €-206.27 Million | €355.40 Million | ▲ +5.4% |
| 2023 | -0.51x | €-134.60 Million | €-145.59 Million | €263.91 Million | ▲ +3.7% |
| 2022 | -0.53x | €-101.47 Million | €-112.31 Million | €191.60 Million | ▲ +55.2% |
| 2021 | -1.18x | €-109.00 Million | €-117.86 Million | €92.24 Million | ▲ +3.5% |
| 2020 | -1.22x | €-103.08 Million | €-117.76 Million | €84.20 Million | ▲ +28.3% |
| 2019 | -1.71x | €-83.14 Million | €-101.48 Million | €48.69 Million | ▼ -1.8% |
| 2018 | -1.68x | €-29.75 Million | €-42.52 Million | €17.74 Million | ▲ +24.6% |
| 2017 | -2.22x | €-13.48 Million | €-16.36 Million | €6.06 Million | — |